Lower Urinary Tract Obstructive Syndrome: Clinical Trials

2 trials for Lower Urinary Tract Obstructive Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1

Follow Lower Urinary Tract Obstructive Syndrome: new trials by email Literature Review of Lower Urinary Tract Obstructive Syndrome trials Research Report on Lower Urinary Tract Obstructive Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Renal Anhydramnios Fetal Therapy
Serial amnioinfusions with isotonic fluid, Spinal needle, Isotonic fluid - Anhydramnios, Potter Syndrome
Phase 1CompletedJohns Hopkins University552018-12-212026-07-01
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Lactated Ringers Solution for Injection - Renal Failure Congenital, Congenital Renal Anomaly Nos
Phase 1RecruitingMayo Clinic402018-10-012026-11-06

Narrower conditions

Hereditary renal agenesis (2)  ·  Congenital Abnormalities (1)  ·  Multicystic Dysplastic Kidney (1)  ·  Multicystic renal dysplasia, bilateral (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Congenital Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Kidney Diseases, Cystic (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Abnormalities (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Ringer's Lactate (2)  ·  Injections (1)  ·  Saline Solution (1)

Sponsors

Johns Hopkins University (1)  ·  Mayo Clinic (1)

Countries

United States (2)

Top investigators

Mauro Schenone, MD (1)  ·  Meredith Atkinson (1)

Results publications

PMID 25004316, PMID 35918190, PMID 38051327, PMID 38615944, PMID 42384373

NIH funding

R01HD100540 (1)